Biogen Inc. buy BMO Capital Markets
Start price
14.02.24
/
50%
€206.60
Target price
14.02.25
€265.53
Performance (%)
-18.61%
Price
17:35
€168.15
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.61%. This prediction currently runs until 14.02.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -3.523% | -3.523% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $295.00 to $285.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat